LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2019

Mar 1, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2019-02-28

Reporting Person: Santini Alexander A (EVP and CCO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-28	Common Stock	M	2352	—	Acquired	7649	Direct
2019-02-28	Common Stock	M	2593	—	Acquired	10242	Direct
2019-02-28	Common Stock	M	8463	—	Acquired	18705	Direct
2019-02-28	Common Stock	F	4544	$5.51	Disposed	14161	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-28	Restricted Stock Units	$	M	2352	Disposed		Common Stock (2352)	Direct
2019-02-28	Restricted Stock Units	$	M	2593	Disposed		Common Stock (2593)	Direct
2019-02-28	Restricted Stock Units	$	M	8463	Disposed		Common Stock (8463)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of common stock.

F2: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.

F3: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.

F4: Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.

F5: Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter.